JOP20200323A1 - طرق لتصنيع تركيبات الأحماض الأمينية - Google Patents
طرق لتصنيع تركيبات الأحماض الأمينيةInfo
- Publication number
- JOP20200323A1 JOP20200323A1 JOP/2020/0323A JOP20200323A JOP20200323A1 JO P20200323 A1 JOP20200323 A1 JO P20200323A1 JO P20200323 A JOP20200323 A JO P20200323A JO P20200323 A1 JOP20200323 A1 JO P20200323A1
- Authority
- JO
- Jordan
- Prior art keywords
- methods
- amino acid
- acid compositions
- manufacturing amino
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Abstract
يوفر الكشف الحالي طرق لتصنيع مستحضرات ممزوجة واسعة النطاق تشتمل على واحد أو أكثر من الأحماض الأمينية حيث يكون للمستحضرات خواص معينة.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862687725P | 2018-06-20 | 2018-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20200323A1 true JOP20200323A1 (ar) | 2020-12-14 |
Family
ID=67226342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2020/0323A JOP20200323A1 (ar) | 2018-06-20 | 2019-12-20 | طرق لتصنيع تركيبات الأحماض الأمينية |
Country Status (17)
Country | Link |
---|---|
US (1) | US11679089B2 (ar) |
EP (1) | EP3810168A1 (ar) |
JP (1) | JP2021529735A (ar) |
KR (1) | KR20210023846A (ar) |
CN (1) | CN112823018A (ar) |
AR (1) | AR115581A1 (ar) |
AU (1) | AU2019288371A1 (ar) |
BR (1) | BR112020025831A2 (ar) |
CA (1) | CA3099762A1 (ar) |
CL (1) | CL2020003277A1 (ar) |
IL (1) | IL279328A (ar) |
JO (1) | JOP20200323A1 (ar) |
MA (1) | MA52957A (ar) |
MX (1) | MX2020013732A (ar) |
SG (1) | SG11202011611XA (ar) |
TW (1) | TW202015668A (ar) |
WO (1) | WO2019246201A1 (ar) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
US11617731B2 (en) | 2017-04-28 | 2023-04-04 | Axcella Health, Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
CU20200012A7 (es) | 2017-08-14 | 2021-02-04 | Axcella Health Inc | Composiciones de aminoácidos para el tratamiento de enfermedad hepática |
WO2019246225A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
WO2019246201A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Methods of manufacturing amino acid compositions |
TW202315605A (zh) | 2021-07-26 | 2023-04-16 | 美商胺細拉健康公司 | 用於治療covid—19急性後期後遺症的胺基酸組合物及方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871550A (en) * | 1986-09-05 | 1989-10-03 | Millman Phillip L | Nutrient composition for athletes and method of making and using the same |
CA2143420C (en) | 1992-12-23 | 1999-01-19 | Phyllis J. B. Acosta | Medical foods for the nutritional support of infant/toddler metabolic diseases |
EP0891719A1 (en) | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
US20010041187A1 (en) | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
DE04759123T1 (de) | 2003-04-07 | 2005-08-18 | Novetide Ltd. | Verfahren zur herstellung cyclischer peptide |
US20040213838A1 (en) | 2003-04-24 | 2004-10-28 | Mazer Terrence B. | Medical food tablets containing free amino acids |
US20070141150A1 (en) | 2003-12-30 | 2007-06-21 | Raghupathi Kandarapu | Pharmaceutical composition |
US20060073254A1 (en) | 2004-10-04 | 2006-04-06 | Steve Catani | No-carb tabletop sweeteners substitute |
JPWO2006062238A1 (ja) | 2004-12-07 | 2008-06-12 | 味の素株式会社 | アミノ酸の微粉末及びその懸濁液 |
US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
WO2011043647A1 (en) * | 2009-10-09 | 2011-04-14 | N.V. Nutricia | Amino acid composition with improved dispersibility |
JP2012136492A (ja) | 2010-12-25 | 2012-07-19 | Shiga Prefecture Seiyaku Kk | 服用感を改善された漢方内服液剤 |
WO2015002527A1 (en) * | 2013-07-05 | 2015-01-08 | N.V. Nutricia | Amino acid composition for use in the treatment of a pdd |
EP3027181A1 (en) | 2013-07-31 | 2016-06-08 | Leeds Beckett University | Dietary supplement |
RU2016110842A (ru) | 2013-09-25 | 2017-10-30 | Пронутриа Биосайенсис, Инк. | Композиции и составы для предотвращения и уменьшения опухолеобразования, пролиферации и инвазии раковых клеток, и способы их получения и применения при лечении раковых заболеваний |
US20180125926A1 (en) | 2013-09-25 | 2018-05-10 | Axcella Health Inc. | Compositions and Formulations and Methods of Production and Use Thereof |
FR3032883B1 (fr) | 2015-02-24 | 2017-03-17 | International Nutrition Res Company | Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques |
JO3543B1 (ar) * | 2015-09-28 | 2020-07-05 | Applied Pharma Res | تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم |
EP4098282A1 (en) * | 2016-02-04 | 2022-12-07 | Czap Research And Development, LLC | Controlled-release and stratified cyclodextrin inclusion complex vehicles |
PL238958B1 (pl) | 2016-06-29 | 2021-10-25 | Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym |
US20180015122A1 (en) * | 2016-07-14 | 2018-01-18 | Companion Supplements, LLC | Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
JOP20190147A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات |
JP2018154598A (ja) | 2017-03-21 | 2018-10-04 | 株式会社明治 | アミノ酸含有顆粒およびその製造方法 |
US11617731B2 (en) | 2017-04-28 | 2023-04-04 | Axcella Health, Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
CU20200012A7 (es) | 2017-08-14 | 2021-02-04 | Axcella Health Inc | Composiciones de aminoácidos para el tratamiento de enfermedad hepática |
CN111295186A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗神经元损伤的氨基酸组合物 |
AR115583A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de las enfermedades y trastornos del hígado |
US20210260010A1 (en) | 2018-06-20 | 2021-08-26 | Axcella Health Inc. | Compositions and methods for the reduction or treatment of inflammation |
KR20210023847A (ko) | 2018-06-20 | 2021-03-04 | 악셀라 헬스 인크. | 쓴맛 아미노산을 포함하는, 요법 및 건강관리용 조성물 |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
EP3810272A1 (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the reduction or treatment of fibrosis |
WO2019246201A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Methods of manufacturing amino acid compositions |
WO2019246225A1 (en) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
CN112689508A (zh) | 2018-06-20 | 2021-04-20 | 胺细拉健康公司 | 减少或治疗胰岛素抗性和代谢病状的组合物和方法 |
-
2019
- 2019-06-19 WO PCT/US2019/037902 patent/WO2019246201A1/en unknown
- 2019-06-19 KR KR1020207035956A patent/KR20210023846A/ko unknown
- 2019-06-19 SG SG11202011611XA patent/SG11202011611XA/en unknown
- 2019-06-19 AR ARP190101694A patent/AR115581A1/es unknown
- 2019-06-19 CN CN201980054581.8A patent/CN112823018A/zh active Pending
- 2019-06-19 AU AU2019288371A patent/AU2019288371A1/en not_active Abandoned
- 2019-06-19 MX MX2020013732A patent/MX2020013732A/es unknown
- 2019-06-19 US US16/446,171 patent/US11679089B2/en active Active
- 2019-06-19 JP JP2020570677A patent/JP2021529735A/ja active Pending
- 2019-06-19 CA CA3099762A patent/CA3099762A1/en active Pending
- 2019-06-19 EP EP19737943.1A patent/EP3810168A1/en active Pending
- 2019-06-19 BR BR112020025831-8A patent/BR112020025831A2/pt unknown
- 2019-06-19 MA MA052957A patent/MA52957A/fr unknown
- 2019-06-20 TW TW108121575A patent/TW202015668A/zh unknown
- 2019-12-20 JO JOP/2020/0323A patent/JOP20200323A1/ar unknown
-
2020
- 2020-12-09 IL IL279328A patent/IL279328A/en unknown
- 2020-12-17 CL CL2020003277A patent/CL2020003277A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW202015668A (zh) | 2020-05-01 |
AU2019288371A1 (en) | 2020-12-03 |
KR20210023846A (ko) | 2021-03-04 |
AR115581A1 (es) | 2021-02-03 |
JP2021529735A (ja) | 2021-11-04 |
CA3099762A1 (en) | 2019-12-26 |
EP3810168A1 (en) | 2021-04-28 |
US20190388374A1 (en) | 2019-12-26 |
IL279328A (en) | 2021-01-31 |
WO2019246201A1 (en) | 2019-12-26 |
CN112823018A (zh) | 2021-05-18 |
SG11202011611XA (en) | 2021-01-28 |
CL2020003277A1 (es) | 2021-07-09 |
MX2020013732A (es) | 2021-02-26 |
US11679089B2 (en) | 2023-06-20 |
BR112020025831A2 (pt) | 2021-03-23 |
MA52957A (fr) | 2021-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20200323A1 (ar) | طرق لتصنيع تركيبات الأحماض الأمينية | |
PH12018501355A1 (en) | Rsv f protein mutants | |
TN2018000276A1 (en) | Inhibitors of receptor-interacting protein kinase 1. | |
CY1124806T1 (el) | Αντισωματα enanti-cd40 και χρησεις αυτων | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
PH12019501357A1 (en) | Anti-ox40 antibodies and their uses | |
PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
MX2020006612A (es) | Compuesto que funciona como inhibidor de proteína de bromodominio y composición. | |
SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
MY189454A (en) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists | |
WO2018081592A3 (en) | Compositions and methods for the production of compounds | |
PH12018502714A1 (en) | Nicotine particles and compositions | |
MX2020001885A (es) | Formulaciones de daptomicina. | |
MX2023005421A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
MX2020008125A (es) | Composiciones que comprenden berberina. | |
MY181478A (en) | Mixed decyl mercaptans compositions and methods of making same | |
WO2018132821A3 (en) | Elastomeric proteins |